A study on Alzheimer's disease examines the effect of omega-3 fatty acids – with memory tests and testing of spinal
Read moreHome ยป
fatty
Closer to human: Mouse model more accurately reproduces fatty liver disease
Human non-alcoholic fatty liver disease (NAFLD) is a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver
Read moreNew study implicates disease-driving B cells in fatty liver disease development
New research from the University of Minnesota Medical School suggests that disease-driving B cells, a white blood cell, play a
Read moreProtein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and
Read moreflagyl doses c diff
Scientists like the John A. Moran Eye Center’s Paul S. Bernstein, MD, Ph.D., know a special class of lipids, or
Read moreCT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)
According to ARRS’ American Journal of Roentgenology (AJR), Fibrosis-4 (FIB-4) and multiple CT findings can identify patients with high-risk nonalcoholic
Read moreModified Parkinson’s drug shows potential in treating nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by excessive fat accumulation in the liver. It can cause serious
Read morePotential early biomarker to track development of non-alcoholic fatty liver disease
Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than
Read more